Global Galectin 3 Market Insights and Forecast to 2031

Report ID: 1564068 | Published Date: Sep 2024 | No. of Page: 90 | Base Year: 2023 | Rating: 3.9 | Webstory: Check our Web story
1 Study Coverage
    1.1 Galectin 3 Product Introduction
    1.2 Market by Type
        1.2.1 Global Galectin 3 Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 GAL-300
        1.2.3 GRMD-03
        1.2.4 ANG-4021
        1.2.5 KTI
        1.2.6 Others
    1.3 Market by Application
        1.3.1 Global Galectin 3 Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Liver Cirrhosis
        1.3.3 Portal Hypertension
        1.3.4 Metastatic Melanoma
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Galectin 3 Sales Estimates and Forecasts 2017-2028
    2.2 Global Galectin 3 Revenue Estimates and Forecasts 2017-2028
    2.3 Global Galectin 3 Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Galectin 3 Sales by Region
        2.4.1 Global Galectin 3 Sales by Region (2017-2022)
        2.4.2 Global Sales Galectin 3 by Region (2023-2028)
    2.5 Global Galectin 3 Revenue by Region
        2.5.1 Global Galectin 3 Revenue by Region (2017-2022)
        2.5.2 Global Galectin 3 Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Galectin 3 Sales by Manufacturers
        3.1.1 Global Top Galectin 3 Manufacturers by Sales (2017-2022)
        3.1.2 Global Galectin 3 Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Galectin 3 in 2021
    3.2 Global Galectin 3 Revenue by Manufacturers
        3.2.1 Global Galectin 3 Revenue by Manufacturers (2017-2022)
        3.2.2 Global Galectin 3 Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Galectin 3 Revenue in 2021
    3.3 Global Galectin 3 Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Galectin 3 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Galectin 3 Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Galectin 3 Sales by Type
        4.1.1 Global Galectin 3 Historical Sales by Type (2017-2022)
        4.1.2 Global Galectin 3 Forecasted Sales by Type (2023-2028)
        4.1.3 Global Galectin 3 Sales Market Share by Type (2017-2028)
    4.2 Global Galectin 3 Revenue by Type
        4.2.1 Global Galectin 3 Historical Revenue by Type (2017-2022)
        4.2.2 Global Galectin 3 Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Galectin 3 Revenue Market Share by Type (2017-2028)
    4.3 Global Galectin 3 Price by Type
        4.3.1 Global Galectin 3 Price by Type (2017-2022)
        4.3.2 Global Galectin 3 Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Galectin 3 Sales by Application
        5.1.1 Global Galectin 3 Historical Sales by Application (2017-2022)
        5.1.2 Global Galectin 3 Forecasted Sales by Application (2023-2028)
        5.1.3 Global Galectin 3 Sales Market Share by Application (2017-2028)
    5.2 Global Galectin 3 Revenue by Application
        5.2.1 Global Galectin 3 Historical Revenue by Application (2017-2022)
        5.2.2 Global Galectin 3 Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Galectin 3 Revenue Market Share by Application (2017-2028)
    5.3 Global Galectin 3 Price by Application
        5.3.1 Global Galectin 3 Price by Application (2017-2022)
        5.3.2 Global Galectin 3 Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Galectin 3 Market Size by Type
        6.1.1 North America Galectin 3 Sales by Type (2017-2028)
        6.1.2 North America Galectin 3 Revenue by Type (2017-2028)
    6.2 North America Galectin 3 Market Size by Application
        6.2.1 North America Galectin 3 Sales by Application (2017-2028)
        6.2.2 North America Galectin 3 Revenue by Application (2017-2028)
    6.3 North America Galectin 3 Market Size by Country
        6.3.1 North America Galectin 3 Sales by Country (2017-2028)
        6.3.2 North America Galectin 3 Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Galectin 3 Market Size by Type
        7.1.1 Europe Galectin 3 Sales by Type (2017-2028)
        7.1.2 Europe Galectin 3 Revenue by Type (2017-2028)
    7.2 Europe Galectin 3 Market Size by Application
        7.2.1 Europe Galectin 3 Sales by Application (2017-2028)
        7.2.2 Europe Galectin 3 Revenue by Application (2017-2028)
    7.3 Europe Galectin 3 Market Size by Country
        7.3.1 Europe Galectin 3 Sales by Country (2017-2028)
        7.3.2 Europe Galectin 3 Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Galectin 3 Market Size by Type
        8.1.1 Asia Pacific Galectin 3 Sales by Type (2017-2028)
        8.1.2 Asia Pacific Galectin 3 Revenue by Type (2017-2028)
    8.2 Asia Pacific Galectin 3 Market Size by Application
        8.2.1 Asia Pacific Galectin 3 Sales by Application (2017-2028)
        8.2.2 Asia Pacific Galectin 3 Revenue by Application (2017-2028)
    8.3 Asia Pacific Galectin 3 Market Size by Region
        8.3.1 Asia Pacific Galectin 3 Sales by Region (2017-2028)
        8.3.2 Asia Pacific Galectin 3 Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Galectin 3 Market Size by Type
        9.1.1 Latin America Galectin 3 Sales by Type (2017-2028)
        9.1.2 Latin America Galectin 3 Revenue by Type (2017-2028)
    9.2 Latin America Galectin 3 Market Size by Application
        9.2.1 Latin America Galectin 3 Sales by Application (2017-2028)
        9.2.2 Latin America Galectin 3 Revenue by Application (2017-2028)
    9.3 Latin America Galectin 3 Market Size by Country
        9.3.1 Latin America Galectin 3 Sales by Country (2017-2028)
        9.3.2 Latin America Galectin 3 Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Galectin 3 Market Size by Type
        10.1.1 Middle East and Africa Galectin 3 Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Galectin 3 Revenue by Type (2017-2028)
    10.2 Middle East and Africa Galectin 3 Market Size by Application
        10.2.1 Middle East and Africa Galectin 3 Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Galectin 3 Revenue by Application (2017-2028)
    10.3 Middle East and Africa Galectin 3 Market Size by Country
        10.3.1 Middle East and Africa Galectin 3 Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Galectin 3 Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Angion Biomedica Corp
        11.1.1 Angion Biomedica Corp Corporation Information
        11.1.2 Angion Biomedica Corp Overview
        11.1.3 Angion Biomedica Corp Galectin 3 Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Angion Biomedica Corp Galectin 3 Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Angion Biomedica Corp Recent Developments
    11.2 Bristol-Myers Squibb Company
        11.2.1 Bristol-Myers Squibb Company Corporation Information
        11.2.2 Bristol-Myers Squibb Company Overview
        11.2.3 Bristol-Myers Squibb Company Galectin 3 Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Bristol-Myers Squibb Company Galectin 3 Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Bristol-Myers Squibb Company Recent Developments
    11.3 Galectin Therapeutics Inc
        11.3.1 Galectin Therapeutics Inc Corporation Information
        11.3.2 Galectin Therapeutics Inc Overview
        11.3.3 Galectin Therapeutics Inc Galectin 3 Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Galectin Therapeutics Inc Galectin 3 Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Galectin Therapeutics Inc Recent Developments
    11.4 GlycoMimetics Inc
        11.4.1 GlycoMimetics Inc Corporation Information
        11.4.2 GlycoMimetics Inc Overview
        11.4.3 GlycoMimetics Inc Galectin 3 Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 GlycoMimetics Inc Galectin 3 Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 GlycoMimetics Inc Recent Developments
    11.5 iTeos Therapeutics SA
        11.5.1 iTeos Therapeutics SA Corporation Information
        11.5.2 iTeos Therapeutics SA Overview
        11.5.3 iTeos Therapeutics SA Galectin 3 Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 iTeos Therapeutics SA Galectin 3 Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 iTeos Therapeutics SA Recent Developments
    11.6 MandalMed Inc
        11.6.1 MandalMed Inc Corporation Information
        11.6.2 MandalMed Inc Overview
        11.6.3 MandalMed Inc Galectin 3 Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 MandalMed Inc Galectin 3 Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 MandalMed Inc Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Galectin 3 Industry Chain Analysis
    12.2 Galectin 3 Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Galectin 3 Production Mode & Process
    12.4 Galectin 3 Sales and Marketing
        12.4.1 Galectin 3 Sales Channels
        12.4.2 Galectin 3 Distributors
    12.5 Galectin 3 Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Galectin 3 Industry Trends
    13.2 Galectin 3 Market Drivers
    13.3 Galectin 3 Market Challenges
    13.4 Galectin 3 Market Restraints
14 Key Findings in The Global Galectin 3 Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
List of Tables
    Table 1. Global Galectin 3 Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of GAL-300
    Table 3. Major Manufacturers of GRMD-03
    Table 4. Major Manufacturers of ANG-4021
    Table 5. Major Manufacturers of KTI
    Table 6. Major Manufacturers of Others
    Table 7. Global Galectin 3 Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 8. Global Galectin 3 Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 9. Global Galectin 3 Sales by Region (2017-2022) & (K Pcs)
    Table 10. Global Galectin 3 Sales Market Share by Region (2017-2022)
    Table 11. Global Galectin 3 Sales by Region (2023-2028) & (K Pcs)
    Table 12. Global Galectin 3 Sales Market Share by Region (2023-2028)
    Table 13. Global Galectin 3 Revenue by Region (2017-2022) & (US$ Million)
    Table 14. Global Galectin 3 Revenue Market Share by Region (2017-2022)
    Table 15. Global Galectin 3 Revenue by Region (2023-2028) & (US$ Million)
    Table 16. Global Galectin 3 Revenue Market Share by Region (2023-2028)
    Table 17. Global Galectin 3 Sales by Manufacturers (2017-2022) & (K Pcs)
    Table 18. Global Galectin 3 Sales Share by Manufacturers (2017-2022)
    Table 19. Global Galectin 3 Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 20. Global Galectin 3 Revenue Share by Manufacturers (2017-2022)
    Table 21. Galectin 3 Price by Manufacturers (2017-2022) &(USD/Pcs)
    Table 22. Global Galectin 3 Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 23. Global Galectin 3 by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Galectin 3 as of 2021)
    Table 24. Galectin 3 Manufacturing Base Distribution and Headquarters
    Table 25. Manufacturers Galectin 3 Product Offered
    Table 26. Date of Manufacturers Enter into Galectin 3 Market
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Galectin 3 Sales by Type (2017-2022) & (K Pcs)
    Table 29. Global Galectin 3 Sales by Type (2023-2028) & (K Pcs)
    Table 30. Global Galectin 3 Sales Share by Type (2017-2022)
    Table 31. Global Galectin 3 Sales Share by Type (2023-2028)
    Table 32. Global Galectin 3 Revenue by Type (2017-2022) & (US$ Million)
    Table 33. Global Galectin 3 Revenue by Type (2023-2028) & (US$ Million)
    Table 34. Global Galectin 3 Revenue Share by Type (2017-2022)
    Table 35. Global Galectin 3 Revenue Share by Type (2023-2028)
    Table 36. Galectin 3 Price by Type (2017-2022) & (USD/Pcs)
    Table 37. Global Galectin 3 Price Forecast by Type (2023-2028) & (USD/Pcs)
    Table 38. Global Galectin 3 Sales by Application (2017-2022) & (K Pcs)
    Table 39. Global Galectin 3 Sales by Application (2023-2028) & (K Pcs)
    Table 40. Global Galectin 3 Sales Share by Application (2017-2022)
    Table 41. Global Galectin 3 Sales Share by Application (2023-2028)
    Table 42. Global Galectin 3 Revenue by Application (2017-2022) & (US$ Million)
    Table 43. Global Galectin 3 Revenue by Application (2023-2028) & (US$ Million)
    Table 44. Global Galectin 3 Revenue Share by Application (2017-2022)
    Table 45. Global Galectin 3 Revenue Share by Application (2023-2028)
    Table 46. Galectin 3 Price by Application (2017-2022) & (USD/Pcs)
    Table 47. Global Galectin 3 Price Forecast by Application (2023-2028) & (USD/Pcs)
    Table 48. North America Galectin 3 Sales by Type (2017-2022) & (K Pcs)
    Table 49. North America Galectin 3 Sales by Type (2023-2028) & (K Pcs)
    Table 50. North America Galectin 3 Revenue by Type (2017-2022) & (US$ Million)
    Table 51. North America Galectin 3 Revenue by Type (2023-2028) & (US$ Million)
    Table 52. North America Galectin 3 Sales by Application (2017-2022) & (K Pcs)
    Table 53. North America Galectin 3 Sales by Application (2023-2028) & (K Pcs)
    Table 54. North America Galectin 3 Revenue by Application (2017-2022) & (US$ Million)
    Table 55. North America Galectin 3 Revenue by Application (2023-2028) & (US$ Million)
    Table 56. North America Galectin 3 Sales by Country (2017-2022) & (K Pcs)
    Table 57. North America Galectin 3 Sales by Country (2023-2028) & (K Pcs)
    Table 58. North America Galectin 3 Revenue by Country (2017-2022) & (US$ Million)
    Table 59. North America Galectin 3 Revenue by Country (2023-2028) & (US$ Million)
    Table 60. Europe Galectin 3 Sales by Type (2017-2022) & (K Pcs)
    Table 61. Europe Galectin 3 Sales by Type (2023-2028) & (K Pcs)
    Table 62. Europe Galectin 3 Revenue by Type (2017-2022) & (US$ Million)
    Table 63. Europe Galectin 3 Revenue by Type (2023-2028) & (US$ Million)
    Table 64. Europe Galectin 3 Sales by Application (2017-2022) & (K Pcs)
    Table 65. Europe Galectin 3 Sales by Application (2023-2028) & (K Pcs)
    Table 66. Europe Galectin 3 Revenue by Application (2017-2022) & (US$ Million)
    Table 67. Europe Galectin 3 Revenue by Application (2023-2028) & (US$ Million)
    Table 68. Europe Galectin 3 Sales by Country (2017-2022) & (K Pcs)
    Table 69. Europe Galectin 3 Sales by Country (2023-2028) & (K Pcs)
    Table 70. Europe Galectin 3 Revenue by Country (2017-2022) & (US$ Million)
    Table 71. Europe Galectin 3 Revenue by Country (2023-2028) & (US$ Million)
    Table 72. Asia Pacific Galectin 3 Sales by Type (2017-2022) & (K Pcs)
    Table 73. Asia Pacific Galectin 3 Sales by Type (2023-2028) & (K Pcs)
    Table 74. Asia Pacific Galectin 3 Revenue by Type (2017-2022) & (US$ Million)
    Table 75. Asia Pacific Galectin 3 Revenue by Type (2023-2028) & (US$ Million)
    Table 76. Asia Pacific Galectin 3 Sales by Application (2017-2022) & (K Pcs)
    Table 77. Asia Pacific Galectin 3 Sales by Application (2023-2028) & (K Pcs)
    Table 78. Asia Pacific Galectin 3 Revenue by Application (2017-2022) & (US$ Million)
    Table 79. Asia Pacific Galectin 3 Revenue by Application (2023-2028) & (US$ Million)
    Table 80. Asia Pacific Galectin 3 Sales by Region (2017-2022) & (K Pcs)
    Table 81. Asia Pacific Galectin 3 Sales by Region (2023-2028) & (K Pcs)
    Table 82. Asia Pacific Galectin 3 Revenue by Region (2017-2022) & (US$ Million)
    Table 83. Asia Pacific Galectin 3 Revenue by Region (2023-2028) & (US$ Million)
    Table 84. Latin America Galectin 3 Sales by Type (2017-2022) & (K Pcs)
    Table 85. Latin America Galectin 3 Sales by Type (2023-2028) & (K Pcs)
    Table 86. Latin America Galectin 3 Revenue by Type (2017-2022) & (US$ Million)
    Table 87. Latin America Galectin 3 Revenue by Type (2023-2028) & (US$ Million)
    Table 88. Latin America Galectin 3 Sales by Application (2017-2022) & (K Pcs)
    Table 89. Latin America Galectin 3 Sales by Application (2023-2028) & (K Pcs)
    Table 90. Latin America Galectin 3 Revenue by Application (2017-2022) & (US$ Million)
    Table 91. Latin America Galectin 3 Revenue by Application (2023-2028) & (US$ Million)
    Table 92. Latin America Galectin 3 Sales by Country (2017-2022) & (K Pcs)
    Table 93. Latin America Galectin 3 Sales by Country (2023-2028) & (K Pcs)
    Table 94. Latin America Galectin 3 Revenue by Country (2017-2022) & (US$ Million)
    Table 95. Latin America Galectin 3 Revenue by Country (2023-2028) & (US$ Million)
    Table 96. Middle East and Africa Galectin 3 Sales by Type (2017-2022) & (K Pcs)
    Table 97. Middle East and Africa Galectin 3 Sales by Type (2023-2028) & (K Pcs)
    Table 98. Middle East and Africa Galectin 3 Revenue by Type (2017-2022) & (US$ Million)
    Table 99. Middle East and Africa Galectin 3 Revenue by Type (2023-2028) & (US$ Million)
    Table 100. Middle East and Africa Galectin 3 Sales by Application (2017-2022) & (K Pcs)
    Table 101. Middle East and Africa Galectin 3 Sales by Application (2023-2028) & (K Pcs)
    Table 102. Middle East and Africa Galectin 3 Revenue by Application (2017-2022) & (US$ Million)
    Table 103. Middle East and Africa Galectin 3 Revenue by Application (2023-2028) & (US$ Million)
    Table 104. Middle East and Africa Galectin 3 Sales by Country (2017-2022) & (K Pcs)
    Table 105. Middle East and Africa Galectin 3 Sales by Country (2023-2028) & (K Pcs)
    Table 106. Middle East and Africa Galectin 3 Revenue by Country (2017-2022) & (US$ Million)
    Table 107. Middle East and Africa Galectin 3 Revenue by Country (2023-2028) & (US$ Million)
    Table 108. Angion Biomedica Corp Corporation Information
    Table 109. Angion Biomedica Corp Description and Major Businesses
    Table 110. Angion Biomedica Corp Galectin 3 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 111. Angion Biomedica Corp Galectin 3 Product Model Numbers, Pictures, Descriptions and Specifications
    Table 112. Angion Biomedica Corp Recent Developments
    Table 113. Bristol-Myers Squibb Company Corporation Information
    Table 114. Bristol-Myers Squibb Company Description and Major Businesses
    Table 115. Bristol-Myers Squibb Company Galectin 3 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 116. Bristol-Myers Squibb Company Galectin 3 Product Model Numbers, Pictures, Descriptions and Specifications
    Table 117. Bristol-Myers Squibb Company Recent Developments
    Table 118. Galectin Therapeutics Inc Corporation Information
    Table 119. Galectin Therapeutics Inc Description and Major Businesses
    Table 120. Galectin Therapeutics Inc Galectin 3 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 121. Galectin Therapeutics Inc Galectin 3 Product Model Numbers, Pictures, Descriptions and Specifications
    Table 122. Galectin Therapeutics Inc Recent Developments
    Table 123. GlycoMimetics Inc Corporation Information
    Table 124. GlycoMimetics Inc Description and Major Businesses
    Table 125. GlycoMimetics Inc Galectin 3 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 126. GlycoMimetics Inc Galectin 3 Product Model Numbers, Pictures, Descriptions and Specifications
    Table 127. GlycoMimetics Inc Recent Developments
    Table 128. iTeos Therapeutics SA Corporation Information
    Table 129. iTeos Therapeutics SA Description and Major Businesses
    Table 130. iTeos Therapeutics SA Galectin 3 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 131. iTeos Therapeutics SA Galectin 3 Product Model Numbers, Pictures, Descriptions and Specifications
    Table 132. iTeos Therapeutics SA Recent Developments
    Table 133. MandalMed Inc Corporation Information
    Table 134. MandalMed Inc Description and Major Businesses
    Table 135. MandalMed Inc Galectin 3 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 136. MandalMed Inc Galectin 3 Product Model Numbers, Pictures, Descriptions and Specifications
    Table 137. MandalMed Inc Recent Developments
    Table 138. Key Raw Materials Lists
    Table 139. Raw Materials Key Suppliers Lists
    Table 140. Galectin 3 Distributors List
    Table 141. Galectin 3 Customers List
    Table 142. Galectin 3 Market Trends
    Table 143. Galectin 3 Market Drivers
    Table 144. Galectin 3 Market Challenges
    Table 145. Galectin 3 Market Restraints
    Table 146. Research Programs/Design for This Report
    Table 147. Key Data Information from Secondary Sources
    Table 148. Key Data Information from Primary Sources
List of Figures
    Figure 1. Galectin 3 Product Picture
    Figure 3. Global Galectin 3 Market Share by Type in 2021 & 2028
    Figure 3. GAL-300 Product Picture
    Figure 4. GRMD-03 Product Picture
    Figure 5. ANG-4021 Product Picture
    Figure 6. KTI Product Picture
    Figure 7. Others Product Picture
    Figure 8. Global Galectin 3 Market Share by Application in 2021 & 2028
    Figure 9. Liver Cirrhosis
    Figure 10. Portal Hypertension
    Figure 11. Metastatic Melanoma
    Figure 12. Others
    Figure 13. Galectin 3 Report Years Considered
    Figure 14. Global Galectin 3 Sales 2017-2028 (K Pcs)
    Figure 15. Global Galectin 3 Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 16. Global Galectin 3 Revenue 2017-2028 (US$ Million)
    Figure 17. Global Galectin 3 Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 18. Global Galectin 3 Sales Market Share by Region (2017-2022)
    Figure 19. Global Galectin 3 Sales Market Share by Region (2023-2028)
    Figure 20. North America Galectin 3 Sales YoY (2017-2028) & (K Pcs)
    Figure 21. North America Galectin 3 Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Europe Galectin 3 Sales YoY (2017-2028) & (K Pcs)
    Figure 23. Europe Galectin 3 Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Asia-Pacific Galectin 3 Sales YoY (2017-2028) & (K Pcs)
    Figure 25. Asia-Pacific Galectin 3 Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. Latin America Galectin 3 Sales YoY (2017-2028) & (K Pcs)
    Figure 27. Latin America Galectin 3 Revenue YoY (2017-2028) & (US$ Million)
    Figure 28. Middle East & Africa Galectin 3 Sales YoY (2017-2028) & (K Pcs)
    Figure 29. Middle East & Africa Galectin 3 Revenue YoY (2017-2028) & (US$ Million)
    Figure 30. The Galectin 3 Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 31. The Top 5 and 10 Largest Manufacturers of Galectin 3 in the World: Market Share by Galectin 3 Revenue in 2021
    Figure 32. Global Galectin 3 Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 33. Global Galectin 3 Sales Market Share by Type (2017-2028)
    Figure 34. Global Galectin 3 Revenue Market Share by Type (2017-2028)
    Figure 35. Global Galectin 3 Sales Market Share by Application (2017-2028)
    Figure 36. Global Galectin 3 Revenue Market Share by Application (2017-2028)
    Figure 37. North America Galectin 3 Sales Market Share by Type (2017-2028)
    Figure 38. North America Galectin 3 Revenue Market Share by Type (2017-2028)
    Figure 39. North America Galectin 3 Sales Market Share by Application (2017-2028)
    Figure 40. North America Galectin 3 Revenue Market Share by Application (2017-2028)
    Figure 41. North America Galectin 3 Sales Share by Country (2017-2028)
    Figure 42. North America Galectin 3 Revenue Share by Country (2017-2028)
    Figure 43. U.S. Galectin 3 Revenue (2017-2028) & (US$ Million)
    Figure 44. Canada Galectin 3 Revenue (2017-2028) & (US$ Million)
    Figure 45. Europe Galectin 3 Sales Market Share by Type (2017-2028)
    Figure 46. Europe Galectin 3 Revenue Market Share by Type (2017-2028)
    Figure 47. Europe Galectin 3 Sales Market Share by Application (2017-2028)
    Figure 48. Europe Galectin 3 Revenue Market Share by Application (2017-2028)
    Figure 49. Europe Galectin 3 Sales Share by Country (2017-2028)
    Figure 50. Europe Galectin 3 Revenue Share by Country (2017-2028)
    Figure 51. Germany Galectin 3 Revenue (2017-2028) & (US$ Million)
    Figure 52. France Galectin 3 Revenue (2017-2028) & (US$ Million)
    Figure 53. U.K. Galectin 3 Revenue (2017-2028) & (US$ Million)
    Figure 54. Italy Galectin 3 Revenue (2017-2028) & (US$ Million)
    Figure 55. Russia Galectin 3 Revenue (2017-2028) & (US$ Million)
    Figure 56. Asia Pacific Galectin 3 Sales Market Share by Type (2017-2028)
    Figure 57. Asia Pacific Galectin 3 Revenue Market Share by Type (2017-2028)
    Figure 58. Asia Pacific Galectin 3 Sales Market Share by Application (2017-2028)
    Figure 59. Asia Pacific Galectin 3 Revenue Market Share by Application (2017-2028)
    Figure 60. Asia Pacific Galectin 3 Sales Share by Region (2017-2028)
    Figure 61. Asia Pacific Galectin 3 Revenue Share by Region (2017-2028)
    Figure 62. China Galectin 3 Revenue (2017-2028) & (US$ Million)
    Figure 63. Japan Galectin 3 Revenue (2017-2028) & (US$ Million)
    Figure 64. South Korea Galectin 3 Revenue (2017-2028) & (US$ Million)
    Figure 65. India Galectin 3 Revenue (2017-2028) & (US$ Million)
    Figure 66. Australia Galectin 3 Revenue (2017-2028) & (US$ Million)
    Figure 67. Taiwan Galectin 3 Revenue (2017-2028) & (US$ Million)
    Figure 68. Indonesia Galectin 3 Revenue (2017-2028) & (US$ Million)
    Figure 69. Thailand Galectin 3 Revenue (2017-2028) & (US$ Million)
    Figure 70. Malaysia Galectin 3 Revenue (2017-2028) & (US$ Million)
    Figure 71. Philippines Galectin 3 Revenue (2017-2028) & (US$ Million)
    Figure 72. Latin America Galectin 3 Sales Market Share by Type (2017-2028)
    Figure 73. Latin America Galectin 3 Revenue Market Share by Type (2017-2028)
    Figure 74. Latin America Galectin 3 Sales Market Share by Application (2017-2028)
    Figure 75. Latin America Galectin 3 Revenue Market Share by Application (2017-2028)
    Figure 76. Latin America Galectin 3 Sales Share by Country (2017-2028)
    Figure 77. Latin America Galectin 3 Revenue Share by Country (2017-2028)
    Figure 78. Mexico Galectin 3 Revenue (2017-2028) & (US$ Million)
    Figure 79. Brazil Galectin 3 Revenue (2017-2028) & (US$ Million)
    Figure 80. Argentina Galectin 3 Revenue (2017-2028) & (US$ Million)
    Figure 81. Middle East and Africa Galectin 3 Sales Market Share by Type (2017-2028)
    Figure 82. Middle East and Africa Galectin 3 Revenue Market Share by Type (2017-2028)
    Figure 83. Middle East and Africa Galectin 3 Sales Market Share by Application (2017-2028)
    Figure 84. Middle East and Africa Galectin 3 Revenue Market Share by Application (2017-2028)
    Figure 85. Middle East and Africa Galectin 3 Sales Share by Country (2017-2028)
    Figure 86. Middle East and Africa Galectin 3 Revenue Share by Country (2017-2028)
    Figure 87. Turkey Galectin 3 Revenue (2017-2028) & (US$ Million)
    Figure 88. Saudi Arabia Galectin 3 Revenue (2017-2028) & (US$ Million)
    Figure 89. UAE Galectin 3 Revenue (2017-2028) & (US$ Million)
    Figure 90. Galectin 3 Value Chain
    Figure 91. Galectin 3 Production Process
    Figure 92. Channels of Distribution
    Figure 93. Distributors Profiles
    Figure 94. Bottom-up and Top-down Approaches for This Report
    Figure 95. Data Triangulation
    Figure 96. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Angion Biomedica Corp
Bristol-Myers Squibb Company
Galectin Therapeutics Inc
GlycoMimetics Inc
iTeos Therapeutics SA
MandalMed Inc
Frequently Asked Questions
Galectin 3 report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Galectin 3 report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Galectin 3 report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Dystrophin

Dystrophin market is segmented by Type and by Application. Players, stakeholders, and other parti ... Read More

Beta-Carotene

Beta-Carotene market is segmented by Type and by Application. Players, stakeholders, and other pa ... Read More

Calcium glycinate

Calcium glycinate market is segmented by Type and by Application. Players, stakeholders, and othe ... Read More